China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China · Delayed Price · Currency is CNY 15.62
+0.06 (0.39%)
Jul 31, 2026, 3:04 PM CST
SHE:300294 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,844 | 2,059 | 1,735 | 2,652 | 2,759 | 2,651 |
Revenue Growth | 1.21% | 18.69% | -34.58% | -3.87% | 4.08% | 5.47% |
Gross Profit Gross Profit Growth | 875.86 | 1,016 | 1,119 | 1,393 | 1,504 | 1,463 |
Operating Income Operating Income Growth | 153.99 | 272.95 | 422.12 | 529.38 | 507.16 | 414.49 |
Net Income Net Income Growth | 3.44 | 112.7 | 396.99 | 237.47 | 432.2 | 344.53 |
Earnings Per Share EPS Growth | 0.01 | 0.22 | 0.79 | 0.47 | 0.86 | 0.79 |
EPS Growth | -99.13% | -72.15% | 68.08% | -45.35% | 8.86% | 29.51% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Biochemical Pharmaceutical Product Biochemical Pharmaceutical Product Growth | 181.66 | 211.84 | 335.11 |
Blood Products Business Blood Products Business Growth | 1,672 | 1,514 | 1,452 |
Offset of Business Segment Offset of Business Segment Growth | -1.14 | - | - |
Other Business Other Business Growth | 8.49 | 10.17 | 9.94 |
Pharmaceutical Distribution Business Pharmaceutical Distribution Business Growth | 197.91 | 2.02 | 757.8 |
Total Total Growth | 2,059 | 1,738 | 2,652 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,876 | 3,231 | 3,499 | 5,324 | 4,726 | 4,284 |
Total Debt Total Debt Growth | 75.26 | 65.59 | 12.51 | 24.45 | 35.36 | 35.58 |
Net Cash (Debt) Net Cash Growth | 2,801 | 3,165 | 3,486 | 5,299 | 4,690 | 4,248 |
Net Cash Growth | -16.05% | -9.22% | -34.21% | 12.99% | 10.41% | 903.09% |
Net Cash Per Share Net Cash Per Share Growth | 5.45 | 6.18 | 6.94 | 10.49 | 9.33 | 9.74 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -23.95 | 61.16 | 299.78 | 641.73 | 596.44 | 1,345 |
Capital Expenditures CapEx Growth | -603.38 | -535.31 | -197.79 | -87.5 | -138.41 | -68.12 |
Free Cash Flow Free Cash Flow Growth | -627.32 | -474.15 | 101.99 | 554.23 | 458.03 | 1,277 |
Free Cash Flow Growth | - | - | -81.60% | 21.00% | -64.14% | 121.72% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 47.49% | 49.32% | 64.50% | 52.54% | 54.52% | 55.21% |
Operating Margin | 8.35% | 13.26% | 24.33% | 19.96% | 18.38% | 15.64% |
Pretax Margin | -1.27% | 5.04% | 27.54% | 13.34% | 19.28% | 16.72% |
Profit Margin | 0.19% | 5.47% | 22.88% | 8.95% | 15.67% | 13.00% |
FCF Margin | -34.01% | -23.03% | 5.88% | 20.90% | 16.60% | 48.19% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.223 | 0.223 | 0.320 | 0.300 | 0.200 | 0.150 |
Dividend Per Share Growth | -30.31% | -30.31% | 6.67% | 50.00% | 33.33% | 130.77% |
Dividend Yield | 1.43% | 0.99% | 1.07% | 0.92% | 0.57% | 0.41% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 2292.91 | 101.12 | 38.46 | 71.52 | 42.66 | 56.13 |
Forward PE | 18.60 | 19.56 | 26.00 | 29.00 | 30.95 | 32.40 |
P/FCF Ratio | - | - | 149.71 | 30.64 | 40.25 | 15.14 |
PS Ratio | 4.27 | 5.53 | 8.80 | 6.40 | 6.68 | 7.30 |